MedsFacts Meta-Analysis covering adverse side effect reports of LOSARTAN patients who developed PETECHIAE.
Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 3 individuals taking LOSARTAN reported PETECHIAE to the FDA. A total of 2341 LOSARTAN drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.
Topics covered: This page is designed to help you determine the relationship, if any, between LOSARTAN and PETECHIAE. In doing so, we compare LOSARTAN with other drugs that cause PETECHIAE, to help you evaluate whether or not LOSARTAN causes PETECHIAE. Likewise, this page shows the most highly-reported side effects of LOSARTAN, so you can see if PETECHIAE ranks among LOSARTAN's most well-known side effects.
The Dashboard explained: The Dashboard first shows general Summary Statistics for LOSARTAN and PETECHIAE, such as the raw number and percentage of patients in FDA reports who used LOSARTAN and developed PETECHIAE. Next, the Dashboard lists the most common reasons (indications) why LOSARTAN was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of LOSARTAN. This pie-chart summarizes, for all FDA reports covering LOSARTAN, whether or not the treating physician felt LOSARTAN (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering LOSARTAN. You may click on any of these side effects to learn more about them, in general, or specifically for LOSARTAN. Finally, we identify the drugs most widely associated with LOSARTAN in FDA literature. You may also click on any of these drugs to view it's dashboard.
Reports of LOSARTAN causing PETECHIAE: 3
Reports of any side effect of LOSARTAN : 2341
Percentage of LOSARTAN patients where PETECHIAE is a reported side effect: 0.1281503630927%
FDA reports of any drug causing PETECHIAE : 3958
Average percentage for all medicated patients where PETECHIAE is reported as a complication: 0.02480640754897%
Most frequent diagnoses/indications for prescribing LOSARTAN:
HYPERTENSION ( 648 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 91 patients )
DRUG USE FOR UNKNOWN INDICATION ( 79 patients )
BLOOD PRESSURE ( 44 patients )
BLOOD PRESSURE ABNORMAL ( 26 patients )
CARDIAC DISORDER ( 22 patients )
BLOOD PRESSURE INCREASED ( 13 patients )
PROPHYLAXIS ( 10 patients )
ESSENTIAL HYPERTENSION ( 6 patients )
CARDIAC REHABILITATION THERAPY ( 5 patients )
Physician opinion on LOSARTAN as adverse event culprit:
Most common side effects for patients taking LOSARTAN:
DYSPNOEA (143 patients)
NAUSEA (142 patients)
DIZZINESS (117 patients)
DRUG INEFFECTIVE (117 patients)
ASTHENIA (113 patients)
HEADACHE (102 patients)
DIARRHOEA (97 patients)
PAIN (94 patients)
BLOOD PRESSURE INCREASED (93 patients)
FATIGUE (88 patients)
Twitter feed for LOSARTAN - Pending/Beta
Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.